packageMargetuximab

margetuximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Margetuximab is a monoclonal antibody that inhibits HER2 and is used as an anticancer drug. It is approved but not authorised in the European Union, and remains investigational for some uses.

Summary written by glm-5.3-flash from Wikidata Q109356831 and the WHO ATC classification; not checked by a person.

name:margetuximab
ATC codes:L01FD06
DrugBank:DB14967
Wikidata:Q109356831
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown